Weihong Liu, Luca S. Dobson, Chen Zhang, Jiahui Sun, Phillip T. Lowe, Yingjian Liu, Hanyi Zhuang, David O’Hagan
{"title":"Exploring Linear mono-, bis- and tris-Acetylene Containing Agonists of the Human Olfactory Receptor OR1A1","authors":"Weihong Liu, Luca S. Dobson, Chen Zhang, Jiahui Sun, Phillip T. Lowe, Yingjian Liu, Hanyi Zhuang, David O’Hagan","doi":"10.1021/acs.jmedchem.5c00282","DOIUrl":null,"url":null,"abstract":"Structure–activity relationship studies on olfactory receptors such as OR1A1 enhance an understanding of the molecular mechanism of olfactory perception. Such receptors are considered to be important in regulating physiological roles beyond olfactory perception. Here a series of linearized ketones, alcohols, and a cyclic ether, extended between the oxygen functionality and a terminal <i>tert</i>-butyl group with either <i>mono</i>-, <i>bis</i>-, or <i>tris</i>-acetylene spacers, was prepared to explore the response of human olfactory receptor OR1A1. The best agonists were <i>bis</i>-acetylene rods combined with an aryl spacer, including the <i>bis</i>-acetylene ketones <b>13</b> and <b>14</b>, as well as the primary aryl-<i>bis</i>-acetylene alcohol <b>20</b> and the corresponding secondary alcohol <b>21</b>. In the latter case, there was a clear stimulatory preference for the (<i>R</i>)-<b>21</b> enantiomer. The experimental data were supported by molecular docking of the various ligands on the OR1A1 homology model. Further molecular dynamics simulations revealed atomic details in the OR1A1 binding pocket.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"37 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.5c00282","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Structure–activity relationship studies on olfactory receptors such as OR1A1 enhance an understanding of the molecular mechanism of olfactory perception. Such receptors are considered to be important in regulating physiological roles beyond olfactory perception. Here a series of linearized ketones, alcohols, and a cyclic ether, extended between the oxygen functionality and a terminal tert-butyl group with either mono-, bis-, or tris-acetylene spacers, was prepared to explore the response of human olfactory receptor OR1A1. The best agonists were bis-acetylene rods combined with an aryl spacer, including the bis-acetylene ketones 13 and 14, as well as the primary aryl-bis-acetylene alcohol 20 and the corresponding secondary alcohol 21. In the latter case, there was a clear stimulatory preference for the (R)-21 enantiomer. The experimental data were supported by molecular docking of the various ligands on the OR1A1 homology model. Further molecular dynamics simulations revealed atomic details in the OR1A1 binding pocket.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.